Delivery Order SPE2DB22D3016-SPE2DB25FAWD7
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,852.40, is for the delivery of REMIFENTANIL 2 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REMIFENTANIL 1 MG VIALS. The contract has a ceiling value of $2,103.90 and is set to expire on July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Remifentanil 1 mg vials. The contract has a ceiling value of $1,755.60 and a period of performance through October 31, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,699.97, is for the delivery of 2 mg vials of the drug Remifentanil. The contract has a period of performance through May 24, 2024 and utilizes a Firm Fixed Price pricing type. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 2 MG VIALS, a pharmaceutical product, with a ceiling value of $10,519.60 and a period of performance ending on March 12, 2025. The contract is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,022.40 firm-fixed-price contract is for the supply of 2 mg vials of the drug remifentanil, a potent opioid analgesic. The award has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,123.67 firm fixed-price contract is for the delivery of Remifentanil 5 mg vials, a specialized pain medication. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,625.68, is for the delivery of 2 mg vials of the medication remifentanil. The contract has an ultimate completion date of April 28, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,731.19 Firm Fixed Price delivery order contract is for the supply of REMIFENTANIL 2 MG VIALS, a specialty medication. The contract has an ultimate completion date of April 3, 2025 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,633.40 fixed-price contract is for the supply of Remifentanil 2 mg vials, a specialty pharmaceutical product used in military treatment facilities. The contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...